Valuation: MINDESTA

Market Cap 3.41M 2.92M 2.73M 2.5M 4.69M 326M 4.75M 32.25M 12.58M 164M 12.79M 12.51M 541M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 3.41M 2.92M 2.73M 2.5M 4.69M 326M 4.76M 32.28M 12.59M 164M 12.8M 12.52M 542M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 2014-09-08
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%+5.26%+4.44%+26.03% 51.22B
-1.71%+2.33%+471.42%+597.87% 45.38B
+2.26%+8.60%+20.19%+92.42% 41.97B
+0.64%+9.19%+39.38%+20.54% 42.15B
-0.93%-4.80%+17.39%+46.60% 31.95B
+0.01%+2.83% - - 16.73B
+2.25%+8.30%+38.20%+154.71% 17.1B
+0.03%+3.41%+7.12%+35.49% 14.76B
+1.55%+5.93%+91.96%+47.66% 13.91B
Average +0.56%+3.19%+86.26%+127.67% 30.58B
Weighted average by Cap. +0.45%+3.13%+103.40%+149.09%

Financials

2024 2025
Net sales - -
Net income -250K -214K -201K -184K -345K -23.94M -349K -2.37M -924K -12.03M -940K -919K -39.78M -156K -134K -125K -114K -215K -14.92M -218K -1.48M -576K -7.49M -585K -573K -24.79M
Net Debt 16.82K 14.41K 13.48K 12.34K 23.16K 1.61M 23.46K 159K 62.11K 808K 63.15K 61.78K 2.67M 3.46K 2.96K 2.77K 2.53K 4.76K 331K 4.82K 32.72K 12.76K 166K 12.97K 12.69K 549K
Logo MINDESTA
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-